{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:26:06Z","timestamp":1772580366435,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>This review discusses the development of selective progestin receptor modulators (<jats:styled-content style=\"fixed-case\">SPRMs<\/jats:styled-content>) for use in women's health and specifically the use of ulipristal acetate (<jats:styled-content style=\"fixed-case\">UPA<\/jats:styled-content>) as emergency contraception (<jats:styled-content style=\"fixed-case\">EC<\/jats:styled-content>) and as a treatment for symptomatic fibroids in women who want to preserve their fertility or avoid a hysterectomy. As an <jats:styled-content style=\"fixed-case\">EC<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> UPA<\/jats:styled-content> 30\u00a0mg should be recommended for women, within 102\u00a0h of unprotected intercourse. As a treatment of fibroids, <jats:styled-content style=\"fixed-case\">UPA<\/jats:styled-content> (5\u00a0mg daily dose) should be administered for periods of three months as a pre\u2010surgical strategy, reducing bleeding and fibroid size and facilitating surgery. A proportion of these patients may even avoid surgery. Future developments will demonstrate whether <jats:styled-content style=\"fixed-case\">UPA<\/jats:styled-content> can be used for other indications such as endometriosis and breast cancer prevention or treatment.<\/jats:p>","DOI":"10.1111\/ajo.12641","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T05:43:01Z","timestamp":1496295781000},"page":"393-399","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The use of selective progestin receptor modulators (<scp>SPRMs<\/scp>) and more specifically ulipristal acetate in the practice of gynaecology"],"prefix":"10.1111","volume":"57","author":[{"given":"Serge","family":"Rozenberg","sequence":"first","affiliation":[{"name":"Department of Obstetrics &amp; Gynaecology CHU Saint\u2010Pierre, Universit\u00e9 Libre de Buxelles, Vrije Universiteit Brussel  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Praet","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynaecology CHU Saint\u2010Pierre, Universit\u00e9 Libre de Buxelles, Vrije Universiteit Brussel  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza","family":"Pazzaglia","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynaecology CHU Saint\u2010Pierre, Universit\u00e9 Libre de Buxelles, Vrije Universiteit Brussel  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Gilles","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynaecology CHU Saint\u2010Pierre, Universit\u00e9 Libre de Buxelles, Vrije Universiteit Brussel  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Manigart","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynaecology CHU Saint\u2010Pierre, Universit\u00e9 Libre de Buxelles, Vrije Universiteit Brussel  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Vandromme","sequence":"additional","affiliation":[{"name":"Department of Obstetrics &amp; Gynaecology CHU Saint\u2010Pierre, Universit\u00e9 Libre de Buxelles, Vrije Universiteit Brussel  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000239440.02284.45"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60101-8"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw023"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000082"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9638"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-016-0255-4"},{"key":"e_1_2_4_8_1","first-page":"933","article-title":"The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy","volume":"294","author":"Herrmann W","year":"1982","journal-title":"C R Seances Acad Sci III"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(95)00020-B"},{"key":"e_1_2_4_10_1","unstructured":"PassaroM PiquionJ MullenNet\u00a0al.Safety and luteal phase effects of the antiprogestin CDB\u20102914 in normally cycling women Endocrine Society Abstracts 227(1997) pp.1\u201337010."},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(98)00067-5"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S25887"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.08.021"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.04.010"},{"issue":"8","key":"e_1_2_4_15_1","first-page":"CD001324","article-title":"Interventions for emergency contraception","author":"Cheng L","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des140"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c8e2aa"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.12.057"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q248"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.018"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.05.012"},{"key":"e_1_2_4_22_1","unstructured":"European Medicines Agency.Press release: Levonorgestrel and Ulipristal remain suitable emergency contraceptives for all women regardless of bodyweight. 30 September 2014. [Accessed 8 February 2016.] Available from URL:http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Emergency_contraceptives_31\/WC500176381.pdf"},{"key":"e_1_2_4_23_1","first-page":"2785","article-title":"A prospective, randomized, pharmacodynamic study of quick\u2010starting a desogestrel progestin\u2010only pill following\u00a0Ulipristal acetate\u00a0for emergency\u00a0contraception","volume":"30","author":"Brache V","year":"2015","journal-title":"Hum Reprod"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2014.08.006"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2014.01.003"},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/1933719114549850"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-200207000-00004"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv030"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.011"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103182"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103180"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e318251035b"},{"key":"e_1_2_4_33_1","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) Ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker LH","year":"2017","journal-title":"Hum Reprod"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2016.10.010"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.02.008"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.09.032"},{"key":"e_1_2_4_37_1","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1106471"},{"key":"e_1_2_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.08.021"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.11.003"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.10.012"},{"key":"e_1_2_4_41_1","first-page":"1439","article-title":"Myoma migration: an unexpected \u201ceffect\u201d with Ulipristal acetate treatment","volume":"20","author":"Willame A","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.06.012"},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1254090"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2017.02.002"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajo.12641","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.12641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:10:37Z","timestamp":1695571837000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.12641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/ajo.12641"],"URL":"https:\/\/doi.org\/10.1111\/ajo.12641","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"2017-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}